Carregant...
Ligand-mediated delivery of RNAi-based therapeutics for the treatment of oncological diseases
RNA interference (RNAi)-based therapeutics (miRNAs, siRNAs) have great potential for treating various human diseases through their ability to downregulate proteins associated with disease progression. However, the development of RNAi-based therapeutics is limited by lack of safe and specific deliver...
Guardat en:
| Publicat a: | NAR Cancer |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8291076/ https://ncbi.nlm.nih.gov/pubmed/34316717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/narcan/zcab030 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|